当前位置:首页 - 行情中心 - 灵康药业(603669) - 财务分析

灵康药业

(603669)

  

流通市值:28.92亿  总市值:28.92亿
流通股本:7.21亿   总股本:7.21亿

灵康药业(603669)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至第三季度实现净利润-0.97亿元,每股收益-0.13元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至第三季度最新股东权益103481.64万元,未分配利润-12050.42万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至第三季度最新总资产180302.66万元,负债76821.02万元。

利润表
报告期2023-09-302023-06-302023-03-312022-12-31
营业总收入150,665,541.41112,920,840.3273,303,587.38289,263,184.49
营业总成本255,792,111.55181,133,436.7494,993,229.26457,425,555.63
营业利润-93,993,126.65-67,764,256.37-20,999,994.59-188,675,372.57
利润总额-95,820,842.98-68,817,416.3-21,191,341.88-188,805,896.46
净利润-96,582,500.85-69,721,337.36-22,991,377.51-195,747,720.64
其他综合收益----
综合收益总额-96,582,500.85-69,721,337.36-22,991,377.51-195,747,720.64
资产负债表
报告期2023-09-302023-06-302023-03-312022-12-31
流动资产合计1,065,423,609.281,055,323,397.551,183,109,830.411,132,043,080.07
非流动资产合计737,603,011.64742,397,914.23724,906,706.53723,421,790.66
资产总计1,803,026,620.921,797,721,311.781,908,016,536.941,855,464,870.73
流动负债合计328,465,667.66303,726,672.42370,545,815.71302,423,356.87
非流动负债合计439,744,535.39432,317,058425,318,426.12417,897,841.24
负债合计768,210,203.05736,043,730.42795,864,241.83720,321,198.11
归属于母公司股东权益合计1,034,816,417.871,061,677,581.361,112,152,295.111,135,143,672.62
股东权益合计1,034,816,417.871,061,677,581.361,112,152,295.111,135,143,672.62
负债和股东权益合计1,803,026,620.921,797,721,311.781,908,016,536.941,855,464,870.73
现金流量表
报告期2023-09-302023-06-302023-03-312022-12-31
经营活动现金流入小计260,896,973.39179,132,604.668,557,911.98419,003,874.95
经营活动现金流出小计282,047,698.08204,959,742.985,425,763.72485,361,116.17
经营活动产生的现金流量净额-21,150,724.69-25,827,138.3-16,867,851.74-66,357,241.22
投资活动现金流入小计599,270,726.35461,885,459.19325,434,466.081,345,381,464.1
投资活动现金流出小计688,928,647.27594,145,279.27434,348,956.341,213,837,938.44
投资活动产生的现金流量净额-89,657,920.92-132,259,820.08-108,914,490.26131,543,525.66
筹资活动现金流入小计118,646,944.44118,294,444.44100,000,000212,363,484.39
筹资活动现金流出小计122,774,585.4121,618,307.5861,139,232.16685,709,376.39
筹资活动产生的现金流量净额-4,127,640.96-3,323,863.1438,860,767.84-473,345,892
汇率变动对现金及现金等价物的影响----
现金及现金等价物净增加额-114,936,286.57-161,410,821.52-86,921,574.16-408,159,607.56
期末现金及现金等价物余额448,275,862.91401,801,327.96475,261,821.28563,212,149.48
TOP↑